nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—Arteriospasm coronary—Fluorouracil—colon cancer	0.0755	0.0755	CcSEcCtD
Phenylephrine—Piloerection—Irinotecan—colon cancer	0.0659	0.0659	CcSEcCtD
Phenylephrine—Ischaemia—Irinotecan—colon cancer	0.0313	0.0313	CcSEcCtD
Phenylephrine—Hypertensive crisis—Capecitabine—colon cancer	0.0276	0.0276	CcSEcCtD
Phenylephrine—Miosis—Irinotecan—colon cancer	0.0274	0.0274	CcSEcCtD
Phenylephrine—Lacrimation—Irinotecan—colon cancer	0.0194	0.0194	CcSEcCtD
Phenylephrine—Rales—Capecitabine—colon cancer	0.0187	0.0187	CcSEcCtD
Phenylephrine—Lacrimation—Fluorouracil—colon cancer	0.0186	0.0186	CcSEcCtD
Phenylephrine—Skin necrosis—Methotrexate—colon cancer	0.0163	0.0163	CcSEcCtD
Phenylephrine—Myocardial ischaemia—Irinotecan—colon cancer	0.0142	0.0142	CcSEcCtD
Phenylephrine—Rales—Methotrexate—colon cancer	0.0139	0.0139	CcSEcCtD
Phenylephrine—Myocardial ischaemia—Fluorouracil—colon cancer	0.0136	0.0136	CcSEcCtD
Phenylephrine—Stinging—Fluorouracil—colon cancer	0.0135	0.0135	CcSEcCtD
Phenylephrine—Extravasation—Vincristine—colon cancer	0.0135	0.0135	CcSEcCtD
Phenylephrine—Extravasation—Irinotecan—colon cancer	0.0131	0.0131	CcSEcCtD
Phenylephrine—Eye irritation—Fluorouracil—colon cancer	0.0128	0.0128	CcSEcCtD
Phenylephrine—Extravasation—Fluorouracil—colon cancer	0.0126	0.0126	CcSEcCtD
Phenylephrine—Lacrimation increased—Irinotecan—colon cancer	0.0124	0.0124	CcSEcCtD
Phenylephrine—Lacrimation increased—Fluorouracil—colon cancer	0.0119	0.0119	CcSEcCtD
Phenylephrine—Keratitis—Capecitabine—colon cancer	0.0118	0.0118	CcSEcCtD
Phenylephrine—Photophobia—Fluorouracil—colon cancer	0.0103	0.0103	CcSEcCtD
Phenylephrine—Myocardial ischaemia—Capecitabine—colon cancer	0.00952	0.00952	CcSEcCtD
Phenylephrine—Extrasystoles—Capecitabine—colon cancer	0.0091	0.0091	CcSEcCtD
Phenylephrine—Eye irritation—Capecitabine—colon cancer	0.00896	0.00896	CcSEcCtD
Phenylephrine—Visual disturbance—Irinotecan—colon cancer	0.00876	0.00876	CcSEcCtD
Phenylephrine—Ventricular extrasystoles—Capecitabine—colon cancer	0.00847	0.00847	CcSEcCtD
Phenylephrine—Lacrimation increased—Capecitabine—colon cancer	0.00831	0.00831	CcSEcCtD
Phenylephrine—Neck pain—Capecitabine—colon cancer	0.00775	0.00775	CcSEcCtD
Phenylephrine—Blood pressure increased—Capecitabine—colon cancer	0.00765	0.00765	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Irinotecan—colon cancer	0.00758	0.00758	CcSEcCtD
Phenylephrine—Skin exfoliation—Capecitabine—colon cancer	0.00731	0.00731	CcSEcCtD
Phenylephrine—Sweating increased—Irinotecan—colon cancer	0.00699	0.00699	CcSEcCtD
Phenylephrine—Extravasation—Methotrexate—colon cancer	0.00653	0.00653	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Vincristine—colon cancer	0.00648	0.00648	CcSEcCtD
Phenylephrine—Myocardial infarction—Vincristine—colon cancer	0.00644	0.00644	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Irinotecan—colon cancer	0.00631	0.00631	CcSEcCtD
Phenylephrine—Myocardial infarction—Irinotecan—colon cancer	0.00627	0.00627	CcSEcCtD
Phenylephrine—Eye pain—Capecitabine—colon cancer	0.00615	0.00615	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Fluorouracil—colon cancer	0.00604	0.00604	CcSEcCtD
Phenylephrine—Myocardial infarction—Fluorouracil—colon cancer	0.00601	0.00601	CcSEcCtD
Phenylephrine—Bradycardia—Irinotecan—colon cancer	0.00585	0.00585	CcSEcCtD
Phenylephrine—Visual impairment—Irinotecan—colon cancer	0.00553	0.00553	CcSEcCtD
Phenylephrine—Cardiac disorder—Vincristine—colon cancer	0.00547	0.00547	CcSEcCtD
Phenylephrine—Skin exfoliation—Methotrexate—colon cancer	0.00544	0.00544	CcSEcCtD
Phenylephrine—Angiopathy—Vincristine—colon cancer	0.00535	0.00535	CcSEcCtD
Phenylephrine—Cardiac disorder—Irinotecan—colon cancer	0.00533	0.00533	CcSEcCtD
Phenylephrine—Mediastinal disorder—Vincristine—colon cancer	0.00531	0.00531	CcSEcCtD
Phenylephrine—Angiopathy—Irinotecan—colon cancer	0.00521	0.00521	CcSEcCtD
Phenylephrine—Immune system disorder—Irinotecan—colon cancer	0.00519	0.00519	CcSEcCtD
Phenylephrine—Mediastinal disorder—Irinotecan—colon cancer	0.00518	0.00518	CcSEcCtD
Phenylephrine—Mental disorder—Vincristine—colon cancer	0.00517	0.00517	CcSEcCtD
Phenylephrine—Arrhythmia—Irinotecan—colon cancer	0.00513	0.00513	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Capecitabine—colon cancer	0.00507	0.00507	CcSEcCtD
Phenylephrine—Abdominal pain upper—Capecitabine—colon cancer	0.00507	0.00507	CcSEcCtD
Phenylephrine—Pulmonary oedema—Methotrexate—colon cancer	0.00507	0.00507	CcSEcCtD
Phenylephrine—Arrhythmia—Fluorouracil—colon cancer	0.00491	0.00491	CcSEcCtD
Phenylephrine—Agitation—Vincristine—colon cancer	0.00472	0.00472	CcSEcCtD
Phenylephrine—Sweating increased—Capecitabine—colon cancer	0.00468	0.00468	CcSEcCtD
Phenylephrine—Vision blurred—Fluorouracil—colon cancer	0.00451	0.00451	CcSEcCtD
Phenylephrine—Syncope—Irinotecan—colon cancer	0.00448	0.00448	CcSEcCtD
Phenylephrine—Hypertension—Vincristine—colon cancer	0.00443	0.00443	CcSEcCtD
Phenylephrine—Loss of consciousness—Irinotecan—colon cancer	0.00439	0.00439	CcSEcCtD
Phenylephrine—Visual disturbance—Methotrexate—colon cancer	0.00436	0.00436	CcSEcCtD
Phenylephrine—Hypertension—Irinotecan—colon cancer	0.00432	0.00432	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Capecitabine—colon cancer	0.00422	0.00422	CcSEcCtD
Phenylephrine—Myocardial infarction—Capecitabine—colon cancer	0.0042	0.0042	CcSEcCtD
Phenylephrine—Nervous system disorder—Vincristine—colon cancer	0.00411	0.00411	CcSEcCtD
Phenylephrine—Chest pain—Fluorouracil—colon cancer	0.00408	0.00408	CcSEcCtD
Phenylephrine—Hyperhidrosis—Vincristine—colon cancer	0.00405	0.00405	CcSEcCtD
Phenylephrine—Shock—Irinotecan—colon cancer	0.00401	0.00401	CcSEcCtD
Phenylephrine—Nervous system disorder—Irinotecan—colon cancer	0.004	0.004	CcSEcCtD
Phenylephrine—Hyperhidrosis—Irinotecan—colon cancer	0.00394	0.00394	CcSEcCtD
Phenylephrine—Bradycardia—Capecitabine—colon cancer	0.00391	0.00391	CcSEcCtD
Phenylephrine—Nervous system disorder—Fluorouracil—colon cancer	0.00383	0.00383	CcSEcCtD
Phenylephrine—Tachycardia—Fluorouracil—colon cancer	0.00381	0.00381	CcSEcCtD
Phenylephrine—Paraesthesia—Vincristine—colon cancer	0.00376	0.00376	CcSEcCtD
Phenylephrine—Visual impairment—Capecitabine—colon cancer	0.0037	0.0037	CcSEcCtD
Phenylephrine—Paraesthesia—Irinotecan—colon cancer	0.00366	0.00366	CcSEcCtD
Phenylephrine—Dyspnoea—Irinotecan—colon cancer	0.00364	0.00364	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Vincristine—colon cancer	0.00362	0.00362	CcSEcCtD
Phenylephrine—Pain—Vincristine—colon cancer	0.00358	0.00358	CcSEcCtD
Phenylephrine—Cardiac disorder—Capecitabine—colon cancer	0.00357	0.00357	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Irinotecan—colon cancer	0.00352	0.00352	CcSEcCtD
Phenylephrine—Paraesthesia—Fluorouracil—colon cancer	0.00351	0.00351	CcSEcCtD
Phenylephrine—Pain—Irinotecan—colon cancer	0.00349	0.00349	CcSEcCtD
Phenylephrine—Angiopathy—Capecitabine—colon cancer	0.00349	0.00349	CcSEcCtD
Phenylephrine—Dyspnoea—Fluorouracil—colon cancer	0.00348	0.00348	CcSEcCtD
Phenylephrine—Immune system disorder—Capecitabine—colon cancer	0.00347	0.00347	CcSEcCtD
Phenylephrine—Mediastinal disorder—Capecitabine—colon cancer	0.00346	0.00346	CcSEcCtD
Phenylephrine—Arrhythmia—Capecitabine—colon cancer	0.00343	0.00343	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00337	0.00337	CcSEcCtD
Phenylephrine—Mental disorder—Capecitabine—colon cancer	0.00337	0.00337	CcSEcCtD
Phenylephrine—Pain—Fluorouracil—colon cancer	0.00334	0.00334	CcSEcCtD
Phenylephrine—Dysgeusia—Capecitabine—colon cancer	0.00328	0.00328	CcSEcCtD
Phenylephrine—Vision blurred—Capecitabine—colon cancer	0.00315	0.00315	CcSEcCtD
Phenylephrine—Tremor—Capecitabine—colon cancer	0.00313	0.00313	CcSEcCtD
Phenylephrine—Urticaria—Fluorouracil—colon cancer	0.0031	0.0031	CcSEcCtD
Phenylephrine—Hypersensitivity—Vincristine—colon cancer	0.00309	0.00309	CcSEcCtD
Phenylephrine—Hypersensitivity—Irinotecan—colon cancer	0.00301	0.00301	CcSEcCtD
Phenylephrine—Syncope—Capecitabine—colon cancer	0.003	0.003	CcSEcCtD
Phenylephrine—Palpitations—Capecitabine—colon cancer	0.00296	0.00296	CcSEcCtD
Phenylephrine—Loss of consciousness—Capecitabine—colon cancer	0.00294	0.00294	CcSEcCtD
Phenylephrine—Hypertension—Capecitabine—colon cancer	0.00289	0.00289	CcSEcCtD
Phenylephrine—Hypersensitivity—Fluorouracil—colon cancer	0.00288	0.00288	CcSEcCtD
Phenylephrine—Chest pain—Capecitabine—colon cancer	0.00285	0.00285	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00283	0.00283	CcSEcCtD
Phenylephrine—Dizziness—Vincristine—colon cancer	0.00277	0.00277	CcSEcCtD
Phenylephrine—Pruritus—Fluorouracil—colon cancer	0.00276	0.00276	CcSEcCtD
Phenylephrine—Visual impairment—Methotrexate—colon cancer	0.00276	0.00276	CcSEcCtD
Phenylephrine—Dizziness—Irinotecan—colon cancer	0.0027	0.0027	CcSEcCtD
Phenylephrine—Shock—Capecitabine—colon cancer	0.00269	0.00269	CcSEcCtD
Phenylephrine—Nervous system disorder—Capecitabine—colon cancer	0.00268	0.00268	CcSEcCtD
Phenylephrine—Tachycardia—Capecitabine—colon cancer	0.00267	0.00267	CcSEcCtD
Phenylephrine—Vomiting—Vincristine—colon cancer	0.00266	0.00266	CcSEcCtD
Phenylephrine—Cardiac disorder—Methotrexate—colon cancer	0.00266	0.00266	CcSEcCtD
Phenylephrine—Skin disorder—Capecitabine—colon cancer	0.00265	0.00265	CcSEcCtD
Phenylephrine—Rash—Vincristine—colon cancer	0.00264	0.00264	CcSEcCtD
Phenylephrine—Hyperhidrosis—Capecitabine—colon cancer	0.00264	0.00264	CcSEcCtD
Phenylephrine—Dermatitis—Vincristine—colon cancer	0.00264	0.00264	CcSEcCtD
Phenylephrine—Headache—Vincristine—colon cancer	0.00262	0.00262	CcSEcCtD
Phenylephrine—Angiopathy—Methotrexate—colon cancer	0.0026	0.0026	CcSEcCtD
Phenylephrine—Vomiting—Irinotecan—colon cancer	0.00259	0.00259	CcSEcCtD
Phenylephrine—Immune system disorder—Methotrexate—colon cancer	0.00258	0.00258	CcSEcCtD
Phenylephrine—Dizziness—Fluorouracil—colon cancer	0.00258	0.00258	CcSEcCtD
Phenylephrine—Mediastinal disorder—Methotrexate—colon cancer	0.00258	0.00258	CcSEcCtD
Phenylephrine—Rash—Irinotecan—colon cancer	0.00257	0.00257	CcSEcCtD
Phenylephrine—Dermatitis—Irinotecan—colon cancer	0.00257	0.00257	CcSEcCtD
Phenylephrine—Headache—Irinotecan—colon cancer	0.00256	0.00256	CcSEcCtD
Phenylephrine—Mental disorder—Methotrexate—colon cancer	0.00251	0.00251	CcSEcCtD
Phenylephrine—Nausea—Vincristine—colon cancer	0.00249	0.00249	CcSEcCtD
Phenylephrine—Vomiting—Fluorouracil—colon cancer	0.00248	0.00248	CcSEcCtD
Phenylephrine—Rash—Fluorouracil—colon cancer	0.00246	0.00246	CcSEcCtD
Phenylephrine—Dermatitis—Fluorouracil—colon cancer	0.00246	0.00246	CcSEcCtD
Phenylephrine—Paraesthesia—Capecitabine—colon cancer	0.00245	0.00245	CcSEcCtD
Phenylephrine—Headache—Fluorouracil—colon cancer	0.00245	0.00245	CcSEcCtD
Phenylephrine—Dysgeusia—Methotrexate—colon cancer	0.00244	0.00244	CcSEcCtD
Phenylephrine—Dyspnoea—Capecitabine—colon cancer	0.00243	0.00243	CcSEcCtD
Phenylephrine—Nausea—Irinotecan—colon cancer	0.00242	0.00242	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Capecitabine—colon cancer	0.00236	0.00236	CcSEcCtD
Phenylephrine—Vision blurred—Methotrexate—colon cancer	0.00235	0.00235	CcSEcCtD
Phenylephrine—Pain—Capecitabine—colon cancer	0.00234	0.00234	CcSEcCtD
Phenylephrine—Nausea—Fluorouracil—colon cancer	0.00232	0.00232	CcSEcCtD
Phenylephrine—Urticaria—Capecitabine—colon cancer	0.00217	0.00217	CcSEcCtD
Phenylephrine—Chest pain—Methotrexate—colon cancer	0.00212	0.00212	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00211	0.00211	CcSEcCtD
Phenylephrine—Hypersensitivity—Capecitabine—colon cancer	0.00201	0.00201	CcSEcCtD
Phenylephrine—Nervous system disorder—Methotrexate—colon cancer	0.00199	0.00199	CcSEcCtD
Phenylephrine—Skin disorder—Methotrexate—colon cancer	0.00197	0.00197	CcSEcCtD
Phenylephrine—Hyperhidrosis—Methotrexate—colon cancer	0.00197	0.00197	CcSEcCtD
Phenylephrine—Pruritus—Capecitabine—colon cancer	0.00193	0.00193	CcSEcCtD
Phenylephrine—Paraesthesia—Methotrexate—colon cancer	0.00183	0.00183	CcSEcCtD
Phenylephrine—Dyspnoea—Methotrexate—colon cancer	0.00181	0.00181	CcSEcCtD
Phenylephrine—Dizziness—Capecitabine—colon cancer	0.00181	0.00181	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Methotrexate—colon cancer	0.00175	0.00175	CcSEcCtD
Phenylephrine—Pain—Methotrexate—colon cancer	0.00174	0.00174	CcSEcCtD
Phenylephrine—Vomiting—Capecitabine—colon cancer	0.00174	0.00174	CcSEcCtD
Phenylephrine—Rash—Capecitabine—colon cancer	0.00172	0.00172	CcSEcCtD
Phenylephrine—Dermatitis—Capecitabine—colon cancer	0.00172	0.00172	CcSEcCtD
Phenylephrine—Headache—Capecitabine—colon cancer	0.00171	0.00171	CcSEcCtD
Phenylephrine—Nausea—Capecitabine—colon cancer	0.00162	0.00162	CcSEcCtD
Phenylephrine—Urticaria—Methotrexate—colon cancer	0.00161	0.00161	CcSEcCtD
Phenylephrine—Hypersensitivity—Methotrexate—colon cancer	0.0015	0.0015	CcSEcCtD
Phenylephrine—Pruritus—Methotrexate—colon cancer	0.00144	0.00144	CcSEcCtD
Phenylephrine—Dizziness—Methotrexate—colon cancer	0.00134	0.00134	CcSEcCtD
Phenylephrine—Vomiting—Methotrexate—colon cancer	0.00129	0.00129	CcSEcCtD
Phenylephrine—Rash—Methotrexate—colon cancer	0.00128	0.00128	CcSEcCtD
Phenylephrine—Dermatitis—Methotrexate—colon cancer	0.00128	0.00128	CcSEcCtD
Phenylephrine—Headache—Methotrexate—colon cancer	0.00127	0.00127	CcSEcCtD
Phenylephrine—Nausea—Methotrexate—colon cancer	0.00121	0.00121	CcSEcCtD
